Literature DB >> 21797718

Hyaluronidase and collagenase increase the transfection efficiency of gene electrotransfer in various murine tumors.

Maja Cemazar1, Muriel Golzio, Gregor Sersa, Jean-Michel Escoffre, Andrej Coer, Suzana Vidic, Justin Teissie.   

Abstract

One of the applications of electroporation/electropulsation in biomedicine is gene electrotransfer, the wider use of which is hindered by low transfection efficiency in vivo compared with viral vectors. The aim of our study was to determine whether modulation of the extracellular matrix in solid tumors, using collagenase and hyaluronidase, could increase the transfection efficiency of gene electrotransfer in histologically different solid subcutaneous tumors in mice. Tumors were treated with enzymes before electrotransfer of plasmid DNA encoding either green fluorescent protein or luciferase. Transfection efficiency was determined 3, 9, and 15 days posttransfection. We demonstrated that pretreatment of tumors with a combination of enzymes significantly increased the transfection efficiency of electrotransfer in tumors with a high extracellular matrix area (LPB fibrosarcoma). In tumors with a smaller extracellular matrix area and less organized collagen lattice, the increase was not so pronounced (SA-1 fibrosarcoma and EAT carcinoma), whereas in B16 melanoma, in which only traces of collagen are present, pretreatment of tumors with hyaluronidase alone was more efficient than pretreatment with both enzymes. In conclusion, our results suggest that modification of the extracellular matrix could improve distribution of plasmid DNA in solid subcutaneous tumors, demonstrated by an increase in transfection efficiency, and thus have important clinical implications for electrogene therapy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21797718      PMCID: PMC3260441          DOI: 10.1089/hum.2011.073

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  46 in total

1.  Two-photon fluorescence correlation microscopy reveals the two-phase nature of transport in tumors.

Authors:  George Alexandrakis; Edward B Brown; Ricky T Tong; Trevor D McKee; Robert B Campbell; Yves Boucher; Rakesh K Jain
Journal:  Nat Med       Date:  2004-01-11       Impact factor: 53.440

2.  Effect of tape stripping and adjuvants on immune response after intradermal DNA electroporation.

Authors:  Gaëlle Vandermeulen; Liévin Daugimont; Hervé Richiardi; Marie-Lise Vanderhaeghen; Nathalie Lecouturier; Bernard Ucakar; Véronique Préat
Journal:  Pharm Res       Date:  2009-04-21       Impact factor: 4.200

3.  In vivo electrically mediated protein and gene transfer in murine melanoma.

Authors:  M P Rols; C Delteil; M Golzio; P Dumond; S Cros; J Teissie
Journal:  Nat Biotechnol       Date:  1998-02       Impact factor: 54.908

4.  High-efficiency gene transfer into skeletal muscle mediated by electric pulses.

Authors:  L M Mir; M F Bureau; J Gehl; R Rangara; D Rouy; J M Caillaud; P Delaere; D Branellec; B Schwartz; D Scherman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

5.  Efficient DNA electrotransfer into tumors.

Authors:  M Bettan; M A Ivanov; L M Mir; F Boissière; P Delaere; D Scherman
Journal:  Bioelectrochemistry       Date:  2000-09       Impact factor: 5.373

6.  Hyaluronidase increases electrogene transfer efficiency in skeletal muscle.

Authors:  Carmela Mennuni; Francesco Calvaruso; Immacolata Zampaglione; Gabriella Rizzuto; Daniela Rinaudo; Ernesta Dammassa; Gennaro Ciliberto; Elena Fattori; Nicola La Monica
Journal:  Hum Gene Ther       Date:  2002-02-10       Impact factor: 5.695

7.  Effective gene transfer to solid tumors using different nonviral gene delivery techniques: electroporation, liposomes, and integrin-targeted vector.

Authors:  Maja Cemazar; Gregor Sersa; John Wilson; Gillian M Tozer; Stephen L Hart; Alenka Grosel; Gabi U Dachs
Journal:  Cancer Gene Ther       Date:  2002-04       Impact factor: 5.987

8.  The impact of extracellular matrix on the chemoresistance of solid tumors--experimental and clinical results of hyaluronidase as additive to cytostatic chemotherapy.

Authors:  G Baumgartner; C Gomar-Höss; L Sakr; E Ulsperger; C Wogritsch
Journal:  Cancer Lett       Date:  1998-09-11       Impact factor: 8.679

9.  Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma.

Authors:  Adil I Daud; Ronald C DeConti; Stephanie Andrews; Patricia Urbas; Adam I Riker; Vernon K Sondak; Pamela N Munster; Daniel M Sullivan; Kenneth E Ugen; Jane L Messina; Richard Heller
Journal:  J Clin Oncol       Date:  2008-11-24       Impact factor: 44.544

10.  Electric pulses used in electrochemotherapy and electrogene therapy do not significantly change the expression profile of genes involved in the development of cancer in malignant melanoma cells.

Authors:  Vid Mlakar; Vesna Todorovic; Maja Cemazar; Damjan Glavac; Gregor Sersa
Journal:  BMC Cancer       Date:  2009-08-26       Impact factor: 4.430

View more
  17 in total

1.  Tumor stromal disrupting agent enhances the anticancer efficacy of docetaxel loaded PEGylated liposomes in lung cancer.

Authors:  Ketan Patel; Ravi Doddapaneni; Nusrat Chowdhury; Cedar Ha Boakye; Gautam Behl; Mandip Singh
Journal:  Nanomedicine (Lond)       Date:  2016-05-12       Impact factor: 5.307

2.  Targeting tumor extracellular matrix activates the tumor-draining lymph nodes.

Authors:  Alexander J Najibi; Ting-Yu Shih; David K Y Zhang; Junzhe Lou; Miguel C Sobral; Hua Wang; Maxence O Dellacherie; Kwasi Adu-Berchie; David J Mooney
Journal:  Cancer Immunol Immunother       Date:  2022-05-07       Impact factor: 6.630

Review 3.  Digesting a Path Forward: The Utility of Collagenase Tumor Treatment for Improved Drug Delivery.

Authors:  Aaron Dolor; Francis C Szoka
Journal:  Mol Pharm       Date:  2018-05-16       Impact factor: 4.939

4.  Combination Approach of YSA Peptide Anchored Docetaxel Stealth Liposomes with Oral Antifibrotic Agent for the Treatment of Lung Cancer.

Authors:  Ketan Patel; Ravi Doddapaneni; Vasanthakumar Sekar; Nusrat Chowdhury; Mandip Singh
Journal:  Mol Pharm       Date:  2016-04-26       Impact factor: 4.939

5.  Gene electrotransfer enhanced by nanosecond pulsed electric fields.

Authors:  Siqi Guo; Diane L Jackson; Niculina I Burcus; Yeong-Jer Chen; Shu Xiao; Richard Heller
Journal:  Mol Ther Methods Clin Dev       Date:  2014-09-17       Impact factor: 6.698

6.  Development and characterization of an enhanced nonviral expression vector for electroporation cancer treatment.

Authors:  Patrick F Forde; Lindsay J Hall; Mira Sadadcharam; Marcle de Kruijf; Gerald C O' Sullivan; Declan M Soden
Journal:  Mol Ther Methods Clin Dev       Date:  2014-04-23       Impact factor: 6.698

Review 7.  Gene Electrotransfer: A Mechanistic Perspective.

Authors:  Christelle Rosazza; Sasa Haberl Meglic; Andreas Zumbusch; Marie-Pierre Rols; Damijan Miklavcic
Journal:  Curr Gene Ther       Date:  2016       Impact factor: 4.391

8.  An engineered bispecific DNA-encoded IgG antibody protects against Pseudomonas aeruginosa in a pneumonia challenge model.

Authors:  Ami Patel; Antonio DiGiandomenico; Ashley E Keller; Trevor R F Smith; Daniel H Park; Stephanie Ramos; Katherine Schultheis; Sarah T C Elliott; Janess Mendoza; Kate E Broderick; Megan C Wise; Jian Yan; Jingjing Jiang; Seleeke Flingai; Amir S Khan; Kar Muthumani; Laurent Humeau; Lily I Cheng; Leslie Wachter-Rosati; C Kendall Stover; Niranjan Y Sardesai; David B Weiner
Journal:  Nat Commun       Date:  2017-09-21       Impact factor: 14.919

9.  Electrochemotherapy by pulsed electromagnetic field treatment (PEMF) in mouse melanoma B16F10 in vivo.

Authors:  Simona Kranjc; Matej Kranjc; Janez Scancar; Jure Jelenc; Gregor Sersa; Damijan Miklavcic
Journal:  Radiol Oncol       Date:  2016-02-16       Impact factor: 2.991

10.  Tumor cell death after electrotransfer of plasmid DNA is associated with cytosolic DNA sensor upregulation.

Authors:  Katarina Znidar; Masa Bosnjak; Nina Semenova; Olga Pakhomova; Loree Heller; Maja Cemazar
Journal:  Oncotarget       Date:  2018-04-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.